ALPS Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Sell |
34,290
-12,811
| -27% | -$605K | 0.01% | 396 |
|
|
2025
Q1 | $1.84M | Sell |
47,101
-3,894
| -8% | -$152K | 0.01% | 360 |
|
|
2024
Q4 | $2.76M | Buy |
50,995
+7,167
| +16% | +$388K | 0.02% | 302 |
|
|
2024
Q3 | $2.21M | Sell |
43,828
-5,214
| -11% | -$263K | 0.01% | 341 |
|
|
2024
Q2 | $2.16M | Buy |
49,042
+6,769
| +16% | +$298K | 0.01% | 326 |
|
|
2024
Q1 | $2.12M | Buy |
42,273
+3,376
| +9% | +$170K | 0.02% | 340 |
|
|
2023
Q4 | $2.35M | Buy |
+38,897
| New | +$2.35M | 0.02% | 312 |
|
|
2022
Q4 | – | Sell |
-20,144
| Closed | -$160K | – | 1069 |
|
|
2022
Q3 | $160K | Sell |
20,144
-11,116
| -36% | -$88.3K | ﹤0.01% | 1017 |
|
|
2022
Q2 | $164K | Buy |
+31,260
| New | +$164K | ﹤0.01% | 1004 |
|